Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
biotech
clinical trials
fda
life sciences
national
national blog main
national top stories
new york top stories
san francisco top stories
spinal muscular atrophy
spinraza
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eisai
gene therapy
indiana blog main
indiana top stories
new york blog main
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
zolgensma
89bio
abbvie
adaptive biotechnologies
adrian krainer
What
bio
drug
roundup
week
alzheimer’s
america
annual
approved
assessed
atrophy
attention
biogen
biotech
communities
conference
continues
convoluted
daily
democrats
dreams
esmo
europe
evrysdi
fda
friday
germany
green
head
headaches
healthcare
holding
home
hosted
insurance
intended
investment
ipo
lights
liquid
medicine
Language
unset
Current search:
spinraza
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More